Effects of the anti-neoplastic agent ET-18-OCH3 and some analogs on the biophysical properties of model membranes

International Journal of Pharmaceutics

Volumn 318, Issue 1-2, 2006, Pages 28-40

  Torrecillas, Alejandro ^a   Aroca Aguilar, J Daniel ^a   Aranda, Francisco J ^a   Gajate, Consuelo ^b,c   Mollinedo, Faustino ^b   Corbalán García, Senena ^a   de Godos, Ana ^a   Gómez Fernández, Juan C ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b CSIC   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

31P NMR; ET 16 OCH3 Ser; ET 18 H; ET 18 OCH3; ET 18 OH; LPC; Model membranes; PAF; PAPC

Indexed keywords

1 O HEXADECYL 2 O METHYL SN GLYCERO 3 PHOSPHOCHOLINE; 1 O OCTADECYL 2 HYDROXY SN GLYCERO 3 PHOSPHOCHOLINE; 1 O OCTADECYL SN GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 ACETYL SN GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 HYDROXY SN GLYCERO 3 PHOSPHOCHOLINE; ANTINEOPLASTIC AGENT; DIMYRISTOYLPHOSPHATIDYLCHOLINE; EDELFOSINE; PHOSPHOLIPID DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ARTIFICIAL MEMBRANE; CELL MEMBRANE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG EFFECT; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID COMPOSITION; LIQUID CRYSTAL; MICELLE; PHASE TRANSITION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; TRANSITION TEMPERATURE; X RAY DIFFRACTION;

ALGORITHMS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOPHYSICAL PHENOMENA; BIOPHYSICS; CALORIMETRY, DIFFERENTIAL SCANNING; DIMYRISTOYLPHOSPHATIDYLCHOLINE; HL-60 CELLS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANES, ARTIFICIAL; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPID ETHERS; X-RAY DIFFRACTION;

EID: 33745512320     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.03.008     Document Type: Article

References (65)

1. Adachi T., Takahashi H., Ohki K., and Hatta I. Interdigitated structure of phospholipid-alcohol systems studied by x-ray diffraction. Biophys. J. 68 (1995) 1850-1855
2. Aroca J.D., Sánchez-Piñera P., Corbalán-García S., Conesa-Zamora P., de Godos A., and Gómez-Fernández J.C. Correlation between the effect of the anti-neoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine on the membrane and the activity of protein kinase C alpha. Eur. J. Biochem. 268 (2001) 6369-6378
3. Berdel W.E., Bausert W.R., Fink U., Rastetter J., and Munder P.G. Anti-tumor action of alkyl-lysophospholipids. Anticancer Res. 1 (1981) 345-352
4. Berdel W.E., Fink U., Egger B., Reichert A., Munder P.G., and Rastetter J. Inhibition by alkyl-lysophospholipids of tritiated thymidine uptake in cells of human malignant urologic tumors. J. Natl. Cancer Inst. 66 (1981) 813-817
5. Berdel W.E., Fromm M., Fink U., Pahlke W., Bicker U., Reichert A., and Rastetter J. Cytotoxicity of thioether-lysophospholipids in leukemias and tumors of human origin. Cancer Res. 43 (1983) 5538-5543
6. Berdel W.E., Greiner E., Fink U., Zanker K.S., Stavrou D., Trappe A., Fahlbusch R., Reichert A., and Rastetter J. Cytotoxic effects of alkyl-lysophospholipids in human brain tumor cells. Oncology 41 (1984) 140-145
7. + exchanger activity by an alkyl-lysophospholipid analogue in a human breast cancer cell line. Biochem. Pharmacol. 51 (1996) 1153-1158
8. Böttcher C.J.F., Van Gent C.M., and Pries C. A rapid and sensitive sub-micro phosphorus determination. Anal. Chim. Acta 24 (1961) 203-204
9. Brachwitz H., and Vollgraf C. Analogs of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells. Pharmacol. Ther. 66 (1995) 39-82
10. Burdzy K., Munder P.G., Fisher H.Z., and Westphal O. Increase in the phagocytosis of peritoneal macrophages by lysolecithin. Z. Naturforsch. B 19 (1964) 1118-1120
11. 31P NMR lineshapes. Biochim. Biophys. Acta 603 (1980) 63-69
12. Conesa-Zamora P., Mollinedo F., Corbalán-García S., and Gomez-Fernandez J.C. A comparative study of the effect of the antineoplasic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine and some homologous compounds on PKCα and PKCε. Biochim. Biophys. Acta 1687 (2005) 110-119
13. Cullis P.R., and de Kruijff B. Lipid polymorphism and the functional roles of lipids in biological membranes. Biochim. Biophys. Acta 559 (1979) 399-420
14. Denizot Y., Desplat V., Drouet M., Bertin F., and Melloni B. Is there a role of platelet-activating factor in human lung cancer?. Lung Cancer 33 (2001) 195-202
15. Dick D.L., and Lawrence D.S. Physicochemical behavior of cytotoxic ether lipids. Biochemistry 31 (1992) 8252-8257
16. Epand R.M. Relationship of phospholipid hexagonal phases to biological phenomena. Biochem. Cell Biol. 68 (1990) 17-23
17. Gajate C., and Mollinedo F. The antitumor ether lipid ET-18-OCH(3) induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells. Blood 98 (2001) 3860-3863
18. Gajate C., and Mollinedo F. Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH(3) (edelfosine), a proapoptotic agent in tumor cells. Curr. Drug Metab. 3 (2002) 491-525
19. Gajate C., Del Canto-Janez E., Acuna A.U., Amat-Guerri F., Geijo E., Santos-Beneit A.M., Veldman R.J., and Mollinedo F. Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis. J. Exp. Med. 200 (2004) 353-365
20. Gajate C., Fonteriz R.I., Cabaner C., Álvarez-Noves G., Álvarez-Rodríguez Y., Modolell M., and Mollinedo F. Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis. Int. J. Cancer 85 (2000) 674-682
21. Grau A., Ortiz A., de Godos A., and Gomez-Fernandez J.C. A biophysical study of the interaction of the lipopeptide antibiotic iturin A with aqueous phospholipid bilayers. Arch. Biochem. Biophys. 377 (2000) 315-323
22. Haugland H.K., Nygaard S.J., and Tysnes O.B. Combined effect of alkyl-lysophospholipid and vincristine on proliferation, migration and invasion in human glioma cell lines in vitro. Anticancer Res. 19 (1999) 149-156
23. Hayashi H., Kudo I., Inoue K., Nomura H., and Nojima S. Macrophage activation by PAF incorporated into dipalmitoylphosphatidylcholine-cholesterol liposomes. J. Biochem. (Tokyo) 97 (1985) 1255-1258
24. 31P NMR spectroscopy. Correlation between the conformational changes of the protein and the lipid bilayer. Biochemistry 30 (1991) 9084-9089
25. Hochhuth C., Berkovic D., Eibl H., Unger C., and Doenecke D. Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells. J. Cancer Res. Clin. Oncol. 116 (1990) 459-466
26. Hoffman D.R., Thomas V.L., and Snyder F. Inhibition of cellular transport systems by alkyl phospholipid analogs in HL-60 human leukemia cells. Biochim. Biophys. Acta 1127 (1992) 74-80
27. 3. Lipids 22 (1987) 884-890
28. Huang C., Mason J.T., Stephenson F.A., and Levin I.W. Polymorphic phase behavior of platelet-activating factor. Biophys. J. 49 (1986) 587-595
29. Kosano H., and Takatani O. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid. Cancer Res. 48 (1988) 6033-6036
30. Kucera L.S., Iyer N., Leake E., Raben A., Modest E.J., Daniel L.W., and Piantadosi C. Novel membrane-interactive ether lipid analogs that inhibit infectious HIV-1 production and induce defective virus formation. AIDS Res. Hum. Retroviruses 6 (1990) 491-501
31. Lohmeyer M., McNaughton L., Hunt S.P., and Workman P. Stimulation of intracellular free calcium increases by platelet-activating factor in HT29 colon carcinoma cells. Spectrofluorimetric and preliminary spatio-temporal analysis using confocal laser scanning fluorescence imaging microscopy. Biochem. Pharmacol. 47 (1994) 975-985
32. Lóez-Garcia F., Villalaín J., Gómez-Fernández J.C., and Quinn P.J. The phase behavior of mixed aqueous dispersions of dipalmitoyl derivatives of phosphatidylcholine and diacylglycerol. Biophys. J. 66 (1994) 1991-2004
33. Lu J., Xiao Y.J., Baudhuin L.M., Hong G., and Xu Y. Role of ether-linked lysophosphatidic acids in ovarian cancer cells. J. Lipid Res. 43 (2002) 463-476
34. Luzatti V. X-Ray diffraction studies of lipid-water systems. In: Chapman D. (Ed). Biological Membranes (1968), Academic Press, London, UK 71-123
35. Luzzati V., and Husson F. The structure of the liquid-crystalline phases of lipid-water systems. J. Cell. Biol. 12 (1962) 207-219
36. Marasco Jr. C.J., Piantadosi C., Meyer K.L., Morris-Natschke S., Ishaq K.S., Small G.W., and Daniel L.W. Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C. J. Med. Chem. 33 (1990) 985-992
37. Maurer N., Prenner E., Paltauf F., and Glatter O. Phase behavior of the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphochloline. Biochim. Biophys. Acta 1192 (1994) 167-176
38. Mavromoustakos T., Calogeropoulou T., Koufaki M., Kolocouris A., Daliani I., Demetzos C., Meng Z., Makriyannis A., Balzarini J., and De Clercq E. Ether phospholipid-AZT conjugates possessing anti-HIV and antitumor cell activity. Synthesis, conformational analysis, and study of their thermal effects on membrane bilayers. J. Med. Chem. 44 (2001) 1702-1709
39. Mavromoustakos T., Theodoropoulou E., Yang D.P., Lin S.Y., Koufaki M., and Makriyannis A. The conformational properties of the antineoplastic ether lipid 1-thiohexadecyl-2-O-methyl-sn-glycero-3-phosphocholine. Chem. Phys. Lipids 84 (1996) 21-34
40. L. Cancer Res. 57 (1997) 1320-1328
41. 3. Biochem. Biophys. Res. Commun. 192 (1993) 603-609
42. Munder P.G., and Westphal O. Antitumoral and other biomedical activities of synthetic ether lysophospholipids. Chem. Immunol. 49 (1990) 206-235
43. Nasu K., Narahara H., Matsui N., Kawano Y., Tanaka Y., and Miyakawa I. Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. Mol. Hum. Reprod. 5 (1999) 548-553
44. Ngwenya B.Z., Fiavey N.P., and Mogashoa M.M. Activation of peritoneal macrophages by orally administered ether analogues of lysophospholipids. Proc. Soc. Exp. Biol. Med. 197 (1991) 91-97
45. Noseda A., Godwin P.L., and Modest E.J. Effects of antineoplastic ether lipids on model and biological membranes. Biochim. Biophys. Acta 945 (1988) 92-100
46. 31P NMR and X-ray diffraction study. J. Lipid Mediat. 3 (1991) 311-332
47. Paltauf F. Ether lipids in biomembranes. Chem. Phys. Lipids 74 (1994) 101-139
48. Paul W.E., Brown M., Hornbeck P., Mizuguchi J., Ohara J., Rabin E., Snapper C., and Tsang W. Regulation of B-lymphocyte activation, proliferation, and differentiation. Ann. N.Y. Acad. Sci. 505 (1987) 82-89
49. Rand R.P., Fuller N., Parsegian V.A., and Rau D.C. Variation in hydration forces between neutral phospholipids bilayers: evidence for hydration attraction. Biochemistry 27 (1988) 771-772
50. Ruiter G.A., Zerp S.F., Bartelink H., van Blitterswijk W.J., and Verheij M. Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway. Anticancer Drugs 14 (2003) 167-173
51. Salgado J., Villalaín J., and Gómez-Fernández J.C. Effects of platelet-activating factor and related lipids on dielaidoylphosphatidylethanolamine by DSC, FTIR and NMR. Biochim. Biophys. Acta 1145 (1993) 284-292
52. Sánchez-Piñera P., Aranda F.J., Micol V., de Godos A., and Gómez-Fernández J.C. Modulation of polymorphic properties of dielaidoylphosphatidylethanolamine by the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine. Biochim. Biophys. Acta 1417 (1999) 202-210
53. II) phase, and non-lamellar phase transitions of lipids. Biochim. Biophys. Acta 1031 (1990) 1-69
54. Tardieu A., Luzatti V., and Reman F.C. Structure and polymorphism of the hydrocarbon chains of lipids: a study of lecithin-water phases. J. Mol. Biol. 75 (1973) 711-733
55. 31P-nuclear magnetic resonance. Eur. Biophys. J. 29 (2000) 184-195
56. Van der Luit A.H., Budde M., Ruurs P., Verheij M., and van Blitterswijk W.J. Alkyl-lysophospholipid accumulates in lipid rafts and induces apoptosis via raft-dependent endocytosis and inhibition of phosphatidylcholine synthesis. J. Biol. Chem. 277 (2002) 39541-39547
57. Vogler W.R., Whigham E., Bennett W.D., and Olson A.C. Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines. Exp. Hematol. 13 (1985) 629-633
58. Wagner F., Rottem S., Held H.D., Uhlig S., and Zahringer U. Ether lipids in the cell membrane of Mycoplasma fermentans. Eur. J. Biochem. 267 (2000) 6276-6286
59. Wieder T., Haase A., Geilen C.C., and Orfanos C.E. The effect of two synthetic phospholipids on cell proliferation and phosphatidylcholine biosynthesis in Madin-Darby canine kidney cells. Lipids 30 (1995) 389-393
60. Wierenga P.K., Setroikromo R., Vellenga E., and Kampinga H.H. Purging of acute myeloid leukaemia cells from stem cell grafts by hyperthermia: enhancement of the therapeutic index by the tetrapeptide AcSDKP and the alkyl-lysophospholipid ET-18-OCH(3). Br. J. Haematol. 111 (2000) 1145-1152
61. Winter I., Pabst G., Rappolt M., and Lohner K. Refined structure of 1,2-diacyl-P-O-ethylphosphatidylcholine bilayer membranes. Chem. Phys. Lipids 112 (2001) 137-150
62. Xie X.Q., Moring J., and Makriyannis A. Differential scanning calorimetry and small angle X-ray diffraction study of the interaction of (R)-PAF, (R)-ET-18-OMe and (R)-Lyso-PAF with model membranes. Life Sci. 61 (1997) 909-923
63. Xie X., Lin S., Moring J., and Makriyannis A. Interdigitation of bilayers from ether lipid analogs: (R)-PAF, (R)-Lyso-PAF and the antineoplastic (R)-ET-18-Ome. Biochim. Biophys. Acta 1283 (1996) 111-118
64. Zhou X., and Arthur G. 1-O-Octadecyl-2-O-methylglycerophosphocholine inhibits protein kinase C-dependent phosphorylation of endogenous proteins in MCF-7 cells. Biochem. J. 324 (1997) 897-902
65. Zidovetzki R. Role of lipid membrane structure in the mechanism of activation of protein kinase C and phospholipase A2. Curr. Top. Memb. 44 (1997) 255-283